Age range (mean age) [years] |
35–80 (52) |
35–84 (54) |
36–85 (55) |
Sex, n (%) |
|
|
|
male |
810 (56.8) |
774 (57.7) |
679 (57.3) |
female |
615 (43.2) |
568 (42.3) |
507 (42.7) |
Grade of SSR (index sting), n (%) |
|
|
|
Grade I |
122 (8.6) |
.. |
.. |
Grade II |
700 (49.1) |
.. |
.. |
Grade III |
589 (41.3) |
.. |
.. |
Grade IV |
14 (1.0) |
.. |
.. |
Antihypertensive treatment, n (%) |
|
|
|
no medication |
1,035 (72.6) |
1,001 (74.6) |
886 (74.7) |
β-blockers |
148 (10.4) |
123 (9.2) |
105 (8.9) |
ACEI |
169 (11.9) |
159 (11.9) |
136 (11.5) |
β-blockers and ACEI |
71 (5.0) |
58 (4.3) |
55 (4.6) |
Cardiovascular disease, n (%) |
|
|
|
no disease |
845 (59.3) |
801 (59.7) |
715 (60.3) |
coronary heart disease or hypertension |
571 (40.1) |
533 (39.7) |
463
(39.0) |
Causal venom, n (%) |
|
|
|
Bee |
320 (22.5) |
351 (26.2) |
297 (25.0) |
Vespid |
838 (58.8) |
923 (68.8) |
829 (69.9) |
Bee & vespid |
206 (14.5) |
67 (5.0) |
57 (4.8) |
Basal tryptase level, n (%) |
|
|
|
≤ 11.4µg/L |
1,159 (81.3) |
1,092 (81.4) |
972 (82.0) |
> 11.4µg/L |
127 (8.9) |
121 (9.0) |
108
(9.1) |